Interesting facts
Interesting Facts about 1-[3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]-4-(1-piperidyl)piperidine-4-carboxamide
This compound, often referred to in scientific literature as a complex synthetic derivative, is notable for its unique structural features and potential applications in medicinal chemistry. Here are some intriguing aspects of this compound:
- Pharmacological Interest: This compound includes a benzazepine moiety, which is linked to various biological activities. Such structures are frequently researched for their efficacy in treating neurological disorders.
- Chlorine Substitution: The presence of a chlorine atom can significantly enhance the lipophilicity of the compound, potentially influencing its pharmacokinetic properties and receptor binding affinity.
- Piperidine Rings: The integration of piperidine rings in its structure suggests that this compound might exhibit interesting interactions at various biological targets, making it a subject of interest in drug design.
- Structure-Activity Relationship (SAR): Scientists are often interested in the SAR of compounds like this one, as modifications can lead to varying degrees of activity, side effects, and selectivity for different biological targets.
- Research Applications: Compounds with such intricate structures are frequently evaluated in preclinical trials, showcasing their potential to lead to new therapeutic agents.
In summary, 1-[3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]-4-(1-piperidyl)piperidine-4-carboxamide is not just a compound; it embodies a window into advanced medicinal chemistry, with ongoing research revealing its possible therapeutic implications. As noted by researchers, “The complex interplay of structure and function continues to drive innovation in drug discovery.”
Synonyms
Clocapramine
47739-98-0
Clocapramina
Clocapramine [INN]
Clocapraminum
3-Chlorocarpipramine
UNII-6EEL1GB72K
Clocapraminum [INN-Latin]
Clocapramina [INN-Spanish]
Y 4153 [as hydrochloride]
Clocapramine (INN)
DTXSID1057749
CLOCAPRAMINE [MI]
6EEL1GB72K
CLOCAPRAMINE [WHO-DD]
clocapramine hydrochloride
1'-(3-(3-Chloro-10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl)(1,4'-bipiperidine)-4'-carboxamide
DTXCID2031538
Clocapramine dihydrochloride
Clocarpramine;3-Chlorocarpipramine
1-[3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]-4-piperidin-1-ylpiperidine-4-carboxamide
Clocapraminum (INN-Latin)
Clocapramina (INN-Spanish)
Y 4153 (AS HYDROCHLORIDE)
(1,4'-BIPIPERIDINE)-4'-CARBOXAMIDE, 1'-(3-(3-CHLORO-10,11-DIHYDRO-5H-DIBENZ(B,F)AZEPIN-5-YL)PROPYL)-
1'-[3-(3-Chloro-10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl][1,4'-bipiperidine]-4'-carboxamide dihydrochloride
1-(3-(14-chloro-2-azatricyclo(9.4.0.03,?)pentadeca-1(11),3,5,7,12,14-hexaen-2-yl)propyl)-4-(piperidin-1-yl)piperidine-4-carboximidic acid
1-(3-{14-chloro-2-azatricyclo[9.4.0.03,?]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}propyl)-4-(piperidin-1-yl)piperidine-4-carboximidic acid
SCHEMBL34251
CHEMBL2104103
CHEBI:135778
HY-B2073
Tox21_113731
AKOS040732832
CS-6604
DB09003
NCGC00253595-01
DA-72276
CAS-47739-98-0
NS00068378
D07718
Q5134765
1'-[3-(3-Chloro-10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)propyl]-[1,4'-bipiperidine]-4'-carboxamide Dihydrochloride; 5H-Dibenz[b,f]azepine [1,4'-Bipiperidine]-4'-carboxamide derivative; 3-Chloro-5-[3-(4-piperidino-4-carbamoylpiperidino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine Dihydrochloride; Clofekton; Y 4153
3-chloro-5-(3-(4-piperidino-4-carbamoylpiperidino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine dihydrochloride monohydrate
Clocarpramine; 5H-Dibenz[b,f]azepine [1,4'-bipiperidine]-4'-carboxamide Deriv.; 3-Chlorocarpipramine; CCP; 1'-[3-(3-Chloro-10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)propyl][1,4'-bipiperidine]-4'-carboxamide;
Solubility of 1-[3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]-4-(1-piperidyl)piperidine-4-carboxamide (C18H18ClN3O)
Understanding the solubility of 1-[3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]-4-(1-piperidyl)piperidine-4-carboxamide is crucial for its application in various chemical and pharmaceutical contexts. This compound exhibits unique solubility characteristics due to its intricate molecular structure, which can be influenced by several factors, including:
Generally speaking, compounds of this nature often demonstrate:
It is therefore essential to consider the specific solubility profile when formulating this compound for use in medicinal chemistry, as it may influence bioavailability and therapeutic efficacy. As with many pharmaceuticals, the solubility can vary greatly under different conditions, making it a critical parameter to study thoroughly.